BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24632718)

  • 41. Comparison of dopamine and norepinephrine in shock.
    Romero CM
    N Engl J Med; 2010 Jun; 362(24):2328; author reply 2330-1. PubMed ID: 20554990
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of cardiogenic shock following myocardial infarct].
    Röhl D; Summers D
    Dtsch Med Wochenschr; 1973 Aug; 98(33):1537-9. PubMed ID: 4542202
    [No Abstract]   [Full Text] [Related]  

  • 43. Vasopressor use in cardiogenic shock.
    Levy B; Klein T; Kimmoun A
    Curr Opin Crit Care; 2020 Aug; 26(4):411-416. PubMed ID: 32487842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug therapy in cardiogenic shock.
    Ramdohr B
    Int J Clin Pharmacol; 1973 Apr; 7(2):118-26. PubMed ID: 4731279
    [No Abstract]   [Full Text] [Related]  

  • 45. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants.
    Meyer S; Löffler G; Polcher T; Gottschling S; Gortner L
    Acta Paediatr; 2006 Oct; 95(10):1309-12. PubMed ID: 16982509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The physiologic basis for treatment of shock associated with myocardial infarction.
    Gunnar RM; Pietras RJ; Stavrakos C; Loeb HS; Tobin JR
    Med Clin North Am; 1967 Jan; 51(1):69-81. PubMed ID: 4869243
    [No Abstract]   [Full Text] [Related]  

  • 47. Mechanism and treatment of myocardial infarction shock.
    Mason DT
    Singapore Med J; 1973 Sep; 14(3):261-3. PubMed ID: 4777875
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiac performance and metabolism in shock due to acute myocardial infarction in man: response to catecholomines and mechanical cardiac assist.
    Mueller H; Ayres SM; Giannelli S; Conklin EF; Mazzara JT; Grace WJ
    Trans N Y Acad Sci; 1972 Apr; 34(4):309-33. PubMed ID: 4502562
    [No Abstract]   [Full Text] [Related]  

  • 49. Dopamine versus norepinephrine in the treatment of shock.
    Nathan Coxford R; Lang E; Dowling S
    CJEM; 2011 Nov; 13(6):395-7. PubMed ID: 22436478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cardiogenic shock following acute myocardial infarct (current attitudes on pathology, physiopathology and therapy)].
    Modrić B; Rukavina Z
    Vojnosanit Pregl; 1976 Nov; 33(6):419-24. PubMed ID: 1014408
    [No Abstract]   [Full Text] [Related]  

  • 51. Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy.
    Takkunen J; Oilinki O; Huhti E; Vuopala U; Koivisto O
    Acta Med Scand; 1972 Sep; 192(3):165-70. PubMed ID: 5055261
    [No Abstract]   [Full Text] [Related]  

  • 52. [Shock in myocardial infarct].
    Hayat JC; Perret C
    Schweiz Rundsch Med Prax; 1970 May; 59(20):727-9. PubMed ID: 5487771
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
    Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B
    Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Vasopressin as a rescue vasopressor agent. Treatment of selected cardiogenic shock states].
    Mayr VD; Luckner G; Jochberger S; Wenzel V; Hasibeder WR; Dünser MW
    Anaesthesist; 2007 Oct; 56(10):1017-20, 1022-3. PubMed ID: 17594065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
    Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
    Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of cardiogenic shock by prolonged administration of norepinephrine.
    ENGLISH A
    Can Med Assoc J; 1953 Jun; 68(6):596-8. PubMed ID: 13059717
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacologic support in cardiogenic shock.
    Rude RE
    Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prevention of ischemia associated with acute myocardial infarction].
    Forrester JS; Chaterjee K
    Coeur Med Interne; 1974; 13(1):11-20. PubMed ID: 4849467
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical appraisal of shock following acute myocardial infarction.
    Mir MA; Rees S; Yahya AM; Williams JD; Reeves TL
    Cardiology; 1974; 59(2):69-82. PubMed ID: 4434361
    [No Abstract]   [Full Text] [Related]  

  • 60. [Myocardial infarction and cardiogenic shock].
    Buerke M; Weilemann LS; Blank R
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S31-5. PubMed ID: 24446041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.